{
 "drug": "Pramlintide Acetate Injection",
 "asOf": "2026-08-25",
 "status": "discontinuing",
 "since": "10/27/2025",
 "dayN": 302,
 "cat": "Endocrinology/Metabolism",
 "companies": [
  "AstraZeneca AB"
 ],
 "reasons": [],
 "records": [
  {
   "discontinued_date": "10/27/2025",
   "update_type": "New",
   "initial_posting_date": "10/27/2025",
   "package_ndc": "0310-6627-02",
   "generic_name": "Pramlintide Acetate Injection",
   "contact_info": "800-236-9933",
   "related_info": "Discontinuation of the manufacture of the drug.",
   "openfda": {
    "application_number": [
     "NDA021332"
    ],
    "brand_name": [
     "SYMLINPEN"
    ],
    "generic_name": [
     "PRAMLINTIDE ACETATE"
    ],
    "manufacturer_name": [
     "AstraZeneca Pharmaceuticals LP"
    ],
    "product_ndc": [
     "0310-6627",
     "0310-6615"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "SUBCUTANEOUS"
    ],
    "substance_name": [
     "PRAMLINTIDE ACETATE"
    ],
    "rxcui": [
     "861042",
     "861043",
     "861044",
     "861045"
    ],
    "spl_id": [
     "a84753f1-6ac5-4a47-a382-29972938ccaa"
    ],
    "spl_set_id": [
     "4aea30ff-eb0d-45c1-b114-3127966328ff"
    ],
    "package_ndc": [
     "0310-6615-02",
     "0310-6627-02"
    ],
    "unii": [
     "726I6TE06G"
    ]
   },
   "update_date": "10/27/2025",
   "therapeutic_category": [
    "Endocrinology/Metabolism"
   ],
   "dosage_form": "Injection",
   "presentation": "SymlinPen® 120 , Injection, 1000 ug/1 mL (NDC 0310-6627-02)",
   "company_name": "AstraZeneca AB",
   "status": "To Be Discontinued"
  },
  {
   "discontinued_date": "10/27/2025",
   "update_type": "New",
   "initial_posting_date": "10/27/2025",
   "package_ndc": "0310-6615-02",
   "generic_name": "Pramlintide Acetate Injection",
   "contact_info": "800-236-9933",
   "related_info": "Discontinuation of the manufacture of the drug.",
   "openfda": {
    "application_number": [
     "NDA021332"
    ],
    "brand_name": [
     "SYMLINPEN"
    ],
    "generic_name": [
     "PRAMLINTIDE ACETATE"
    ],
    "manufacturer_name": [
     "AstraZeneca Pharmaceuticals LP"
    ],
    "product_ndc": [
     "0310-6615",
     "0310-6627"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "SUBCUTANEOUS"
    ],
    "substance_name": [
     "PRAMLINTIDE ACETATE"
    ],
    "rxcui": [
     "861042",
     "861043",
     "861044",
     "861045"
    ],
    "spl_id": [
     "a84753f1-6ac5-4a47-a382-29972938ccaa"
    ],
    "spl_set_id": [
     "4aea30ff-eb0d-45c1-b114-3127966328ff"
    ],
    "package_ndc": [
     "0310-6615-02",
     "0310-6627-02"
    ],
    "unii": [
     "726I6TE06G"
    ]
   },
   "update_date": "10/27/2025",
   "therapeutic_category": [
    "Endocrinology/Metabolism"
   ],
   "dosage_form": "Injection",
   "presentation": "SymlinPen® 60 , Injection, 1000 ug/1 mL (NDC 0310-6615-02)",
   "company_name": "AstraZeneca AB",
   "status": "To Be Discontinued"
  }
 ]
}